Related references
Note: Only part of the references are listed.SIRT1 and AMPK Mediate Hypoxia-Induced Resistance of Non-Small Cell Lung Cancers to Cisplatin and Doxorubicin
Dong Hoon Shin et al.
CANCER RESEARCH (2014)
Targeted therapy for non-small-cell lung cancer: past, present and future
Patrick M. Forde et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2013)
Description of health problem
T. Brown et al.
HEALTH TECHNOLOGY ASSESSMENT (2013)
MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
Hongping Xia et al.
HEPATOLOGY (2013)
Maintenance Chemotherapy for Advanced Non-Small-Cell Lung Cancer: New Life for an Old Idea
David E. Gerber et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer
M. Cortes-Sempere et al.
ONCOGENE (2013)
Klotho Sensitizes Human Lung Cancer Cell Line to Cisplatin via PI3k/Akt Pathway
Yan Wang et al.
PLOS ONE (2013)
Gefitinib or Erlotinib as Maintenance Therapy in Patients with Advanced Stage Non-Small Cell Lung Cancer: A Systematic Review
Xiaofeng Chen et al.
PLOS ONE (2013)
Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer
Shanthi Ganesh et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5
Xiang-hua Liu et al.
BMC CANCER (2012)
Molecular mechanisms underlying the role of microRNAs (miRNAs) in anticancer drug resistance and implications for clinical practice
Elisa Giovannetti et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2012)
microRNA regulation of cell viability and drug sensitivity in lung cancer
Liqin Du et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells
Xin Fu et al.
FEBS LETTERS (2012)
Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion
Florence Grise et al.
HEPATOLOGY (2012)
MiR-196a Is Upregulated in Gastric Cancer and Promotes Cell Proliferation by Downregulating p27kip1
Ming Sun et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Selective and Cell-Active Inhibitors of the USP1/UAF1 Deubiquitinase Complex Reverse Cisplatin Resistance in Non-small Cell Lung Cancer Cells
Junjun Chen et al.
CHEMISTRY & BIOLOGY (2011)
Alterations of microRNAs in Cisplatin-resistant Human Non-small Cell Lung Cancer Cells (A549/DDP)
Qi Wang et al.
EXPERIMENTAL LUNG RESEARCH (2011)
Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine
N. Vinolas et al.
LUNG CANCER (2011)
Curcumin promotes apoptosis in A549/DDP multidrug-resistant human lung adenocarcinoma cells through an miRNA signaling pathway
Jian Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
MicroRNA and drug resistance
J. Ma et al.
CANCER GENE THERAPY (2010)
Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance
Zhiwei Wang et al.
DRUG RESISTANCE UPDATES (2010)
Chronic cisplatin treatment promotes enhanced damage repair and tumor progression in a mouse model of lung cancer
Trudy G. Oliver et al.
GENES & DEVELOPMENT (2010)
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
Tetsuya Mitsudomi et al.
LANCET ONCOLOGY (2010)
miR-138 might reverse multidrug resistance of leukemia cells
Xiaohong Zhao et al.
LEUKEMIA RESEARCH (2010)
Elevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of Survivin
S. Wang et al.
ONCOGENE (2010)
microRNA miR-196a-2 and Breast Cancer: A Genetic and Epigenetic Association Study and Functional Analysis
Aaron E. Hoffman et al.
CANCER RESEARCH (2009)
miR-196a Regulates Proliferation and Osteogenic Differentiation in Mesenchymal Stem Cells Derived From Human Adipose Tissue
Yeon Jeong Kim et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells
Carl Christoph Schimanski et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Ken A. Olaussen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
